Literature DB >> 2658843

Streptococcal cause of erysipelas and cellulitis in adults. A microbiologic study using a direct immunofluorescence technique.

P Bernard1, C Bedane, M Mounier, F Denis, G Catanzano, J M Bonnetblanc.   

Abstract

We prospectively studied 42 adult patients with acute dermis and soft-tissue infections (27 with erysipelas and 15 with acute cellulitis) involving the lower limb in all except one case. Streptococcus organisms (groups A, C, D, and G) were researched in skin biopsy specimens by a direct immunofluorescent (DIF) technique using commercially available antibodies. Our results showed that DIF gives a sensitivity of 0.70 for the in situ detection of streptococci in cases of erysipelas and cellulitis. With the obvious contribution of this DIF technique, streptococcal pathogens could be detected in situ and grouped in 19 of 27 cases of erysipelas (group A, 13; group B, 1; group C, 1; and group G, 4) and in ten of 15 cases of cellulitis (group A, 9; group B, 1). Combined data, including conventional cultures, DIF studies, and serologic findings, established that Streptococcus organisms, especially Streptococcus pyogenes (A), were, in nearly all cases, responsible for both erysipelas (26/27 cases) and acute cellulitis (11/15 cases) involving the lower limb in adults.

Entities:  

Mesh:

Year:  1989        PMID: 2658843

Source DB:  PubMed          Journal:  Arch Dermatol        ISSN: 0003-987X


  25 in total

1.  Risk factors for erysipelas of the leg (cellulitis): case-control study.

Authors:  A Dupuy; H Benchikhi; J C Roujeau; P Bernard; L Vaillant; O Chosidow; B Sassolas; J C Guillaume; J J Grob; S Bastuji-Garin
Journal:  BMJ       Date:  1999-06-12

2.  Virulence properties of erysipelas-associated group A streptococci.

Authors:  A Norrby; B Eriksson; M Norgren; C J Rönström; A C Sjöblom; K Karkkonen; S E Holm
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1992-12       Impact factor: 3.267

3.  Evidence of streptococcal origin of acute non-necrotising cellulitis: a serological study.

Authors:  M Karppelin; T Siljander; A-M Haapala; J Aittoniemi; R Huttunen; J Kere; J Vuopio; J Syrjänen
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2014-11-18       Impact factor: 3.267

4.  Optimal management of uncomplicated skin and skin structure infections of the lower extremity.

Authors:  Warren S Joseph
Journal:  Curr Infect Dis Rep       Date:  2006-09       Impact factor: 3.725

Review 5.  National Athletic Trainers' Association Position Statement: Management of Acute Skin Trauma.

Authors:  Joel W Beam; Bernadette Buckley; William R Holcomb; Mario Ciocca
Journal:  J Athl Train       Date:  2017-01-16       Impact factor: 2.860

6.  Management and morbidity of cellulitis of the leg.

Authors:  N H Cox; G B Colver; W D Paterson
Journal:  J R Soc Med       Date:  1998-12       Impact factor: 5.344

7.  Oral pristinamycin versus standard penicillin regimen to treat erysipelas in adults: randomised, non-inferiority, open trial.

Authors:  Philippe Bernard; Olivier Chosidow; Loïc Vaillant
Journal:  BMJ       Date:  2002-10-19

Review 8.  Drug treatment of skin and soft tissue infections in elderly long-term care residents.

Authors:  B H Lertzman; A A Gaspari
Journal:  Drugs Aging       Date:  1996-08       Impact factor: 3.923

Review 9.  Cellulitis and erysipelas.

Authors:  Andrew D Morris
Journal:  BMJ Clin Evid       Date:  2008-01-02

10.  Cellulitis and erysipelas: prevention.

Authors:  Choon Chiat Oh
Journal:  BMJ Clin Evid       Date:  2015-11-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.